Abstract
Background:
The French nationwide exhaustive hospital discharge database (PMSI) is used for activity-based payment of hospital services. We hypothesized that the release of articles about alcohol and dementia could influence the identification of these diagnoses in PMSI.
Methods:
We analyzed temporal evolution of coding for dementia and other persistent or late-onset cognitive impairment (OPLOCI) due to alcohol and other psychoactive substances in the PMSI database from 2007 to 2017 (285 748 938 inpatient stays). These codings use the International Classification of Diseases, 10th revision (ICD-10).
Results:
The number of inpatient stays with dementia and OPLOCI due to alcohol increased from 34 to 1704 from 2007 to 2017. While the number of diagnosed dementias remained stable at around 400 from 2013, the number of OPLOCIs increased 10-fold from 2013 to 2017. This increase was not found with dementia or OPLOCI due to other psychoactive substances than alcohol.
Conclusion:
Notoriety of a diagnosis in the literature seems to have an impact on the coding.
Keywords: dementia, database, data reuse, alcoholism, clinical coding
Introduction
Dementia is a clinical syndrome caused by neurodegeneration. It involves progressive decline in cognitive ability and capacity for independent living and functioning. 1 The prevalence of dementia is estimated to be over 45 million people and could reach 115 million by 2050. 2
Among lifestyle-related factors for dementia, alcohol holds a special place. 3 Since 1997, low-to-moderate alcohol drinking has been proposed as a protective factor against the development of dementia. 4 -14 Contrasting findings exist, proposing low-to-moderate alcohol drinking as a risk factor 15 -17 or as an unassociated factor. 18 -26
Chronic heavy alcohol drinking seems related to an increased risk of dementia. Heavy alcohol drinking may also be associated with other alcohol-related brain damage conditions (ethanol neurotoxicity, thiamine deficiency, Wernicke–Korsakoff syndrome, hepatic encephalopathy, vascular dementia). Heavy alcohol drinking is associated with other risk factors for dementia. 27 -29
As intervention studies are not workable for alcohol exposure, the best evidence comes from retrospective cohort study and overview of epidemiological studies.
In early 2013, specific diagnosis of alcohol-related dementia has been discussed. 30 In late 2015, a guidance produced by the National Institute for Health and Care Excellence (NICE) highlights that people aged 40 to 64 years who regularly drink alcohol have an increased risk of dementia. 31,32
An association between early-onset dementia and alcohol use disorders has been found in the French nationwide exhaustive hospital discharge database (PMSI) between 2008 and 2013. 29,33
The PMSI is used for activity-based payment of hospital services since 2004. The coding of the activity is the responsibility of the hospital services. In practice, residents and doctors code diagnoses and technical procedures; however, medical information technicians may code using hospitalization reports. Awareness of specific pathologies, via the media and scientific literature, could lead to changes in coding.
It has already been shown that notoriety affected spontaneous reports of event, particularly in the context of pharmacovigilance. 34,35 We hypothesized that the medical coding in the databases is also subject to this notoriety bias and that the release of articles about alcohol and dementia could influence the identification of diagnoses of dementia related to the use of alcohol between 2007 and 2017.
Method
Study Design
This study consists of a retrospective cohort, based on secondary use of the PMSI database (presented later). We included all the inpatient stays between 2007 and 2017 from the website ScanSanté (a technical agency for hospital information).
Data Source
The PMSI database is the French nationwide exhaustive hospital discharge database. 36 The database used in this study comprehends all the inpatient stays, from nonprofit and for-profit acute care hospitals (medicine, surgery, and obstetrics), excluding psychiatric hospitals and rehabilitation care centers. This database includes administrative data (admission and discharge dates and modes), demographic data (age, gender, geographic area), diagnoses encoded in International Classification of Diseases, 10th revision (ICD-10), 37 medical procedure encoded in CCAM (French medical classification for clinical procedures), 38 and other pieces of information. 39 This information is anonymized and can be reused for research purposes. 33 The database comprehends 285 748 938 inpatient stays over 11 years.
Inclusion Criteria
Dementia and related diseases encoding rules have been defined in 2006. 40 Under these rules, we included inpatient stays having one of the following ICD-10 codes as principal diagnosis:
F1073: dementia due to alcohol
F1074: other persistent or late-onset cognitive impairment (OPLOCI) due to alcohol
The national coding recommendation for alcohol-induced dementia dates from March 2006. To ensure that the progression of alcohol-induced dementia was independent of dementia related to the use of other psychoactive substances, we have also analyzed the following codes:
F1173: dementia due to opioids
F1273: dementia due to cannabis
F1373: dementia due to sedatives and hypnotics
F1473: dementia due to cocaine
F1573: dementia due to stimulants
F1673: dementia due to hallucinogens
F1773: dementia due to tobacco
F1873: dementia due to volatile solvents
F1973: dementia due to multiple drugs
For each code, we also included F1*74 for OPLOCI (eg, F1174: other persistent or late-onset cognitive impairment due to opioids).
In comparison, we noted the number of inpatient stays for Alzheimer’s disease or dementia (codings F00 and G30) and for organic mental disorders, including symptomatic disorders: dementia of Alzheimer’s disease, vascular dementia, dementia during other diseases classified elsewhere, unspecified dementia, organic amnesia syndrome, and uninduced delirium; other mental disorders; personality and organic behavior disorders; and organic mental disorder (codings from F00 to F09).
Statistical Analysis
We performed descriptive statistics and reported categorical variables using the number and percentage of cases.
Results
Dementia and OPLOCI Due to Alcohol
From 2007 to 2012, the number of annual inpatient stays with a principal diagnosis of dementia due to alcohol increased from 20 to 432 and then stagnated until 2017.
From 2013, the number of annual inpatient stays with a principal diagnosis of OPLOCI due to alcohol was multiplied by 10 in 4 years (from 120 to 1247), with a sudden increase after 2015 (Figure 1).
Figure 1.
Evolution of inpatient stays for dementia and OPLOCI due to alcohol between 2007 and 2017 in France. OPLOCI indicates other persistent or late-onset cognitive impairment.
Dementia Related to the Use of Other Psychoactive Substances
Between 2007 and 2017, the number of inpatient stays for dementia and OPLOCI due to the use of other psychoactive substances than alcohol remained stable in France, with a peak of 23 in 2014. Unlike alcohol-induced dementia, there was no increase in the number of inpatient stays after this peak (Table 1).
Table 1.
Number of Inpatient Stays for Dementia and OPLOCI Due to the Use of Psychoactive Substances in France.
Principal Diagnosis | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcohol | Dementia | 20 | 95 | 194 | 265 | 337 | 432 | 423 | 413 | 478 | 463 | 457 |
Alcohol | OPLOCI | 14 | 21 | 45 | 72 | 89 | 121 | 120 | 275 | 382 | 924 | 1247 |
Subtotal | 34 | 116 | 239 | 337 | 426 | 553 | 543 | 688 | 860 | 1387 | 1704 | |
Opioids | Subtotal | 0 | 0 | 1 | 1 | 4 | 2 | 1 | 4 | 1 | 1 | 0 |
Cannabis | Subtotal | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 1 |
Sedatives and hypnotics | Subtotal | 1 | 5 | 1 | 3 | 4 | 9 | 7 | 7 | 5 | 1 | 5 |
Cocaine | Subtotal | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
Stimulants | Subtotal | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 0 | 0 |
Hallucinogens | Subtotal | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 0 | 1 | 0 |
Tobacco | Subtotal | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
Volatile solvents | Subtotal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Multiple drugs | Subtotal | 0 | 1 | 1 | 0 | 4 | 2 | 1 | 5 | 3 | 2 | 5 |
Alzheimer’s disease or dementia | 46 313 | 49 108 | 45 706 | 41 792 | 4137 | 37 928 | 3844 | 31 097 | 29 235 | 28 716 | 25 856 | |
Organic mental disorders | 70 145 | 75 685 | 76 021 | 78 464 | 82 176 | 83 417 | 83 728 | 83 079 | 84 193 | 87 628 | 86 421 | |
Inpatient stays (total) | 23 339 533 | 23 781 314 | 24 297 929 | 24 709 773 | 25 259 627 | 25 828 027 | 26 476 016 | 27 087 492 | 27 600 941 | 28 538 316 | 28 829 970 |
Abbreviation: OPLOCI, other persistent or late-onset cognitive impairment.
Discussion
We observed a 3-fold increase in the number of inpatient stays with a principal diagnosis of dementia or OPLOCI due to alcohol from 2013 to 2017. This increase was not found with dementia or OPLOCI due to other psychoactive substances than alcohol.
Several hypotheses could explain our results. First, hospitalizations of patients with dementia may have increased over the 11-year period. It seems unlikely that in a study with a 15-year follow-up, the annual rate of hospitalization of patient with dementia was stable and represented 16.3 per 100 person years (95% CI 15.0-17.7). 41 Second, dementia or OPLOCI due to alcohol may have increased. Again, it seems unlikely that the number has increased by a factor of 50 in a few recent years. Assuming that the prevalence of dementia and related diseases is globally stable from 2008 to 2017, the observed variations may be due to a change in coding practices. 42 Thus, this trend may be due to the release of international publications about alcohol-related dementia. 3,11 -14,17,27,30,28 After the NHS communication and guidance in 2015 and the communication of a French team in 2016, the total number of dementia and OPLOCI due to alcohol coded in PMSI increased from 860 to 1704 in 2 years. 31,33 Notoriety of a diagnosis in the literature seems to have an impact on the use of its coding, as we have previously suggested concerning vascular dementia. 43
The principal strength of our study is to study all inpatient stays in France over 11 consecutive years, for a total of 285 748 938 inpatient stays.
Our study has potential limitations. The ICD-10 codes for inpatient stays were registered for billing purposes, and we did not confirm them versus clinical records. The use of the PMSI for activity-based payment of hospital services can lead to undercoding diseases that have no financial impact. Since 2012, government agency in charge of the PMSI database has been working on the Ovalide tool, a PMSI data validation tool, which will make it possible to identify low quality in PMSI data. The use of hospital coding to define the diagnosis is a recognized way of counting the cases of dementia. 44 Our results suggest that coding recommendation about alcohol-related dementia is not respected because it is probable that alcoholic dementia is much larger, moreover in France. 45 We study here the number of inpatient stays; some patients may have had several stays. Besides, we were interested in the evolution of coding, and there is no reason to believe that the annual number of stays of patients with alcohol-related dementia may have changed between 2007 and 2017.
Defining and identifying dementias in the major French administrative databases is an issue of interest: a recent review proposed several algorithms, 2 of which have been validated. 46 Furthermore, dementia diagnosis requires fulfilling diagnostic criteria, such criteria exist for Alzheimer’s disease, 47,48 frontotemporal dementia, 49 vascular dementia, 50,51 and dementia with Lewy bodies. 52,53 There is no specific recommendation concerning alcohol-related dementias by the French Haute autorité de santé (equivalent to the British NICE) and no clear criteria for alcohol-related dementia. 30
Conclusion
The findings of this study raise several issues: about care—we note the discrete recent emergence of alcohol-related dementia diagnosis and about research—notoriety of a diagnosis in the literature seems to have an impact on the use of its coding. Thus, it is important to keep in mind the notoriety of the diagnosis studied at the time of its analysis.
Footnotes
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The authors received no financial support for the research, authorship, and/or publication of this article.
ORCID iD: Michaël Rochoy
https://orcid.org/0000-0002-8865-3748
References
- 1. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. The Lancet. 2017;390(10113):2673–2734. doi:10.1016/S0140-6736(17)31363-6. [DOI] [PubMed] [Google Scholar]
- 2. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75.e2. doi:10.1016/j.jalz.2012.11.007. [DOI] [PubMed] [Google Scholar]
- 3. Piazza-Gardner AK, Gaffud TJB, Barry AE. The impact of alcohol on Alzheimer’s disease: a systematic review. Aging Ment Health. 2013;17(2):133–146. doi:10.1080/13607863.2012.742488. [DOI] [PubMed] [Google Scholar]
- 4. Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris). 1997;153(3):185–192.0 [PubMed] [Google Scholar]
- 5. Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J Clin Epidemiol. 2002;55(10):959–964. [DOI] [PubMed] [Google Scholar]
- 6. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156(5):445–453. [DOI] [PubMed] [Google Scholar]
- 7. Bachman DL, Green RC, Benke KS, Cupples LA, Farrer LA, MIRAGE Study Group. Comparison of Alzheimer’s disease risk factors in white and African American families. Neurology. 2003;60(8):1372–1374. [DOI] [PubMed] [Google Scholar]
- 8. Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen M. A 2-year follow-up study of alcohol consumption and risk of dementia. Clin Neurol Neurosurg. 2006;108(4):378–383. doi:10.1016/j.clineuro.2005.06.005. [DOI] [PubMed] [Google Scholar]
- 9. Ogunniyi A, Hall KS, Gureje O, et al. Risk factors for incident Alzheimer’s disease in African Americans and Yoruba. Metab Brain Dis. 2006;21(2-3):235–240. doi:10.1007/s11011-006-9017-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing. 2008;37(5):505–512. doi:10.1093/ageing/afn095. [DOI] [PubMed] [Google Scholar]
- 11. Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17(7):542–555. [DOI] [PubMed] [Google Scholar]
- 12. García AM, Ramón-Bou N, Porta M. Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer’s disease. J Alzheimers Dis. 2010;20(2):577–586. doi:10.3233/JAD-2010-1399. [DOI] [PubMed] [Google Scholar]
- 13. Neafsey EJ, Collins MA. Moderate alcohol consumption and cognitive risk. Neuropsychiatr Dis Treat. 2011;7:465–484. doi:10.2147/NDT.S23159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Weyerer S, Schäufele M, Wiese B, et al. Current alcohol consumption and its relationship to incident dementia: results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age Ageing. 2011;40(4):456–463. doi:10.1093/ageing/afr007. [DOI] [PubMed] [Google Scholar]
- 15. Fratiglioni L, Ahlbom A, Viitanen M, Winblad B. Risk factors for late-onset Alzheimer’s disease: a population-based, case-control study. Ann Neurol. 1993;33(3):258–266. doi:10.1002/ana.410330306. [DOI] [PubMed] [Google Scholar]
- 16. Harwood DG, Barker WW, Loewenstein DA, et al. A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. Neurology. 1999;52(3):551–556. [DOI] [PubMed] [Google Scholar]
- 17. Harwood DG, Kalechstein A, Barker WW, et al. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease. Int J Geriatr Psychiatry. 2010;25(5):511–518. doi:10.1002/gps.2372. [DOI] [PubMed] [Google Scholar]
- 18. Graves AB, van Duijn CM, Chandra V, et al. Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20(suppl 2):S48–S57. [DOI] [PubMed] [Google Scholar]
- 19. Hebert LE, Scherr PA, Beckett LA, et al. Relation of smoking and alcohol consumption to incident Alzheimer’s disease. Am J Epidemiol. 1992;135(4):347–355. [DOI] [PubMed] [Google Scholar]
- 20. Rosen J, Colantonio A, Becker JT, Lopez OL, DeKosky ST, Moss HB. Effects of a history of heavy alcohol consumption on Alzheimer’s disease. Br J Psychiatry. 1993;163:358–363. [DOI] [PubMed] [Google Scholar]
- 21. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45(6):1161–1168. [DOI] [PubMed] [Google Scholar]
- 22. Tsolaki M, Fountoulakis K, Chantzi E, Kazis A. Risk factors for clinically diagnosed Alzheimer’s disease: a case-control study of a Greek population. Int Psychogeriatr. 1997;9(3):327–341. [DOI] [PubMed] [Google Scholar]
- 23. Broe GA, Creasey H, Jorm AF, et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust N Z J Public Health. 1998;22(5):621–623. [DOI] [PubMed] [Google Scholar]
- 24. Tyas SL, Koval JJ, Pederson LL. Does an interaction between smoking and drinking influence the risk of Alzheimer’s disease? Results from three Canadian data sets. Stat Med. 2000;19(11-12):1685–1696. [DOI] [PubMed] [Google Scholar]
- 25. Ruitenberg A, van Swieten JC, Witteman JCM, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002;359(9303):281–286. doi:10.1016/S0140-6736(02)07493-7. [DOI] [PubMed] [Google Scholar]
- 26. Luchsinger JA, Tang M-X, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia. J Am Geriatr Soc. 2004;52(4):540–546. doi:10.1111/j.1532-5415.2004.52159.x. [DOI] [PubMed] [Google Scholar]
- 27. Kim JW, Lee DY, Lee BC, et al. Alcohol and cognition in the elderly: a review. Psychiatry Investig. 2012;9(1):8–16. doi:10.4306/pi.2012.9.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Kuźma E, Llewellyn DJ, Langa KM, Wallace RB, Lang IA. History of alcohol use disorders and risk of severe cognitive impairment: a 19-year prospective cohort study. Am J Geriatr Psychiatry. 2014;22(10):1047–1054. doi:10.1016/j.jagp.2014.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Schwarzinger M, Pollock BG, Hasan OSM, et al. Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3(3): e124–e132. doi:10.1016/S2468-2667(18)30022-7. [DOI] [PubMed] [Google Scholar]
- 30. Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther. 2013;5(1):3. doi:10.1186/alzrt157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. NICE. Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (guidance and guidelines). https://www.nice.org.uk/guidance/ng16. Published October 2015. Accessed December 23, 2018.
- 32. NHS. Warning about middle-aged drinking and dementia. https://www.nhs.uk/news/neurology/warning-about-middle-aged-drinking-and-dementia/. Published October 2015. Accessed December 23, 2018.
- 33. Schwarzinger M, Thiebaut SP, Rehm J. The neglected role of alcohol use disorders in early-onset dementia: a nationwide study from France. Alzheimers Dement J Alzheimers Assoc. 2016;12(7):P194–P195. [Google Scholar]
- 34. Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf. 2007;30(10):891–898. [DOI] [PubMed] [Google Scholar]
- 35. de Boissieu P, Kanagaratnam L, Abou Taam M, Roux MP, Dramé M, Trenque T. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2014;23(9):989–992. doi:10.1002/pds.3622. [DOI] [PubMed] [Google Scholar]
- 36. Boudemaghe T, Belhadj I. Data resource profile: The French National Uniform Hospital Discharge Data Set Database (PMSI). Int J Epidemiol. 2017;46(2):392d–392d. doi:10.1093/ije/dyw359. [DOI] [PubMed] [Google Scholar]
- 37. World Health Organization. International Classification of Diseases (ICD). WHO. http://www.who.int/classifications/icd/en/#. Published 2008. Accessed December 23, 2018.
- 38. Bousquet C, Trombert B, Souvignet J, Sadou E, Rodrigues JM. Evaluation of the CCAM Hierarchy and Semi Structured Code for Retrieving Relevant Procedures in a Hospital Case Mix Database. AMIA Annu Symp Proc. 2010;2010:61–65. [PMC free article] [PubMed] [Google Scholar]
- 39. Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26(8):954–962. doi:10.1002/pds.4233. [DOI] [PubMed] [Google Scholar]
- 40. Agence technique de l’information sur l’hospitalisation (ATIH). Guides méthodologiques 2009 à 2018. http://www.atih.sante.fr/mco/documentation. Published 2018. Accessed December 23, 2018.
- 41. Rudolph James L., Zanin Nicole M., Jones Richard N., et al. Hospitalization in Community-Dwelling Persons with Alzheimer’s Disease: Frequency and Causes. J Am Geriatr Soc. 2010;58(8):1542–1548. doi:10.1111/j.1532-5415.2010.02924.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Grasset L, Brayne C, Joly P, et al. Trends in dementia incidence: Evolution over a 10-year period in France. Alzheimers Dement. 2016;12(3):272–280. doi:10.1016/j.jalz.2015.11.001. [DOI] [PubMed] [Google Scholar]
- 43. Rochoy M, Chazard E, Gautier S, Bordet R. Vascular dementia encoding in the French nationwide discharge summary database (PMSI): Variability over the 2007-2017 period. Ann Cardiol Angeiol (Paris). November 2018. doi:10.1016/j.ancard.2018.10.011. [DOI] [PubMed] [Google Scholar]
- 44. Launer LJ. Counting dementia: There is no one “best” way. Alzheimers Dement. 2011;7(1):10–14. doi:10.1016/j.jalz.2010.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Cheng C, Huang CL, Tsai CJ, Chou PH, Lin CC, Chang CK. Alcohol-Related Dementia: A Systemic Review of Epidemiological Studies. Psychosomatics. 2017;58(4):331–342. doi:10.1016/j.psym.2017.02.012. [DOI] [PubMed] [Google Scholar]
- 46. Gallini A, Moisan F, Maura G, et al. [Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature]. Rev Epidemiol Sante Publique. 2017;65(suppl 4):S183–S197. doi:10.1016/j.respe.2017.01.115. [DOI] [PubMed] [Google Scholar]
- 47. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939–944. [DOI] [PubMed] [Google Scholar]
- 48. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–746. doi:10.1016/S1474-4422(07)70178-3. [DOI] [PubMed] [Google Scholar]
- 49. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4(11):771–780. doi:10.1016/S1474-4422(05)70223-4. [DOI] [PubMed] [Google Scholar]
- 50. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–260. [DOI] [PubMed] [Google Scholar]
- 51. Sachdev P, Kalaria R, O’Brien J, et al. ; International Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–218. doi:10.1097/WAD.0000000000000034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113–1124. [DOI] [PubMed] [Google Scholar]
- 53. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100. doi:10.1212/WNL.0000000000004058. [DOI] [PMC free article] [PubMed] [Google Scholar]